Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Program
Tonight at 6: It's blamed for more crashes among NC teens than speed and alcohol combined. WRAL Investigates distracted teen driving.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
25.26
-1.01 (-3.84%)
Official Closing Price
Updated: 4:10 PM EDT, Apr 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Pfizer
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
What's Going On With Pfizer Stock On Thursday?
Today 13:51 EDT
GSK initiates legal proceedings against Pfizer and BioNTech over alleged COVID-19 vaccine patent infringement, intensifying high-stakes legal battles in the U.S.
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
Today 8:30 EDT
The radiopharmaceuticals space could be worth up to $25 billion, according to one estimate.
Via
Investor's Business Daily
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
Today 7:54 EDT
Via
Benzinga
The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth
April 24, 2024
Discover the top dividend stocks for prolonged wealth in 2024 in pharmaceuticals, integrated telecommunications, drug retail, and tobacco.
Via
InvestorPlace
3 Speculative Weight Loss Drug Stocks to Bet On for Big Gains
April 24, 2024
These weight loss drug stocks are relatively unknown and brimming with potential following the massive success of Novo Nordisk and Eli Lilly.
Via
InvestorPlace
US Stock: Pfizer
April 23, 2024
Pfizer is engaged in the discovery, development, manufacture, marketing, sale, and distribution of biopharmaceutical products worldwide.
Via
Talk Markets
Pfizer Options Trading: A Deep Dive into Market Sentiment
April 22, 2024
Via
Benzinga
A Closer Look at Pfizer's Options Market Dynamics
April 15, 2024
Via
Benzinga
3 Defensive Stocks To Protect Your Portfolio In 2024
April 23, 2024
Alcohol, tobacco, and drugs as bulwarks against market shocks, and these three stocks are now trading under low ballparks.
Via
Talk Markets
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown
April 23, 2024
Moderna challenges Pfizer and BioNTech in a London patent trial over mRNA vaccine patents. The outcome may reshape the pharmaceutical landscape, impacting future innovations and revenue streams.
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
3 Underappreciated Pharmaceutical Stocks to Buy Before They Surge
April 23, 2024
These are the undervalued pharmaceutical stocks to buy as they have a deep clinical pipeline which will driven earnings and cash flow growth.
Via
InvestorPlace
Better Buy: Pfizer vs. Viking Therapeutics
April 23, 2024
These two pharma stocks have followed distinct paths of late. Which is the better investment?
Via
The Motley Fool
1 No-Brainer Vanguard Fund to Buy Right Now
April 23, 2024
This Vanguard growth fund is home to some of the world's most innovative companies.
Via
The Motley Fool
Is Pfizer Stock a Buy?
April 15, 2024
The pharmaceutical giant is laying the groundwork for its next heyday.
Via
The Motley Fool
3 Blue-Chip Stocks That Will Beat Index Returns Over the Next 3 Years
April 22, 2024
These are the undervalued blue-chip stocks to buy as they represent fundamentally strong ideas poised for accelerated growth.
Via
InvestorPlace
Capturing Consumer Spending on Health Care with XLV
April 22, 2024
Capturing Consumer Spending on Health Care with XLV
Via
News Direct
3 Stocks Under $50 You Can Buy Hand Over Fist Right Now
April 20, 2024
A little up-front investment can go a long way with these three stocks.
Via
The Motley Fool
If You'd Invested $1,000 in Pfizer 5 Years Ago, Here's How Much You'd Have Today
April 18, 2024
The answer to that question will either make you wince or smile.
Via
The Motley Fool
The 3 Most Overlooked Stocks Set for a Triple-Digit Comeback
April 17, 2024
Learn how these overlooked stocks are set for a massive resurgence with leads in pharmaceutical, broadline retail and interactive media.
Via
InvestorPlace
3 No-Brainer Stocks to Buy With $100 Right Now
April 17, 2024
A modest amount of money can go a long way in the stock market when it's put to work in time-tested businesses with well-defined competitive advantages.
Via
The Motley Fool
Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff
April 16, 2024
On Tuesday, Johnson & Johnson (NYSE: JNJ) delivered a rather mixed first quarter report. Adjusted earnings surpassed estimates as sales in its medical devices business surged, while revenue was almost...
Via
Benzinga
Better Growth Play: Merck or The Vanguard Growth Index Fund?
April 15, 2024
Merck's shares are trading in bargain territory. Are they a better growth play than this popular Vanguard fund?
Via
The Motley Fool
Want $1,000 in Annual Dividend Income? Invest $13,200 in These Ultra-High-Yield Dividend Stocks.
April 15, 2024
The average yield from these stocks is more than five times the market average.
Via
The Motley Fool
The Smartest Dividend Stocks to Buy With $400 Right Now
April 13, 2024
These three stocks are bargains with great dividends.
Via
The Motley Fool
2 High-Yield Dividend Stocks You Can Buy Now and Hold Forever
April 12, 2024
These dividend payers have a long history of steady dividend payout raises, and they both offer yields above 6% at recent prices.
Via
The Motley Fool
Is Pfizer Stock the Biggest Bargain in the S&P 500?
April 12, 2024
When something seems too good to be true it might not be.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
If You Can Only Buy One Biotech Stock in April, It Better Be One of These 3 Names
April 11, 2024
Capitalize on the biotech sector's boom with these three top biotech stocks to buy, driven by aging demographics and advanced treatments.
Via
InvestorPlace
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 3% Dividend Yields
April 11, 2024
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
Current Analysis: Pfizer (PFE)
April 10, 2024
Pfizer (PFE) is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion. Over the past year, Pfizer’s share price fell 36.6% from $41.50 to $26.31 as of Wednesday’s...
Via
Talk Markets
Vaccine Player Vaxcyte Has Advantage Over Pfizer, Merck's Pneumococcal Shots - Analyst Says
April 10, 2024
The global PCV market, valued at ~$8 billion annually, is poised for significant growth, estimated to reach ~$12 billion soon. Market dynamics are shifting towards adults, potentially doubling with the...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.